Breaking News

Sharp Invests $10M in Biologics, Injectables Packaging Equipment

Investment includes the installation and validation of two Dividella NeoTopx packaging systems.

By: Contract Pharma

Contract Pharma Staff

Sharp, a global provider of contract packaging and clinical supply services, has made an investment of $10 million in equipment capabilities to directly support client demand in the biologics and injectables market.   The investment includes the installation and validation of two Dividella NeoTopx packaging systems, one intended for Sharp’s Allentown facility in the U.S. and the other for Sharp’s Hamont-Achel site in Belgium.   Dividella’s NeoTopx system is an automated top-loading cartoner ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters